Jennifer Lam - Mar 31, 2022 Form 3 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role: VP of Finance & Administration
Signature: /s/ Jennifer Lam
Stock symbol: RPHM
Transactions as of: Mar 31, 2022
Transactions value $: $0
Form type: 3
Date filed: 4/5/2022, 08:02 PM
Next filing: Dec 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RPHM	Common Stock						15K	Mar 31, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RPHM	Stock Option (right to buy)							Mar 31, 2022	Common Stock	50K	$8.66	Direct	F1
holding	RPHM	Stock Option (right to buy)							Mar 31, 2022	Common Stock	35K	$6.69	Direct	F2
holding	RPHM	Stock Option (right to buy)							Mar 31, 2022	Common Stock	10K	$4.58	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4 of the shares vest and become exercisable on September 10, 2022, and the remaining shares vest in equal monthly installments over the subsequent 36 months, subject to Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) as of each such vesting date.
F2	The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) as of each such vesting date.
F3	The shares vest in a series of 48 successive equal monthly installments measured from March 2, 2022, subject to Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) as of each such vesting date.